Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans

Oliver Langer, Rudolf Karch, Ulrich Müller, Georg Dobrozemsky, Aiman Abrahim, Markus Zeitlinger, Edith Lackner, Christian Joukhadar, Robert Dudczak, Kurt Kletter, Markus Müller and Martin Brunner
Journal of Nuclear Medicine November 2005, 46 (11) 1835-1841;
Oliver Langer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolf Karch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Dobrozemsky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aiman Abrahim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Zeitlinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edith Lackner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Joukhadar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Dudczak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Kletter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Brunner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Because many drugs possess an intracellular site of action, the knowledge of intracellular concentration−time profiles is desirable. In the present study, PET, which measures total (i.e., intracellular, extracellular, and intravascular) concentrations of radiolabeled drugs in tissue, and microdialysis, which determines unbound drug concentrations in the extracellular space fluid of tissue, were combined to describe the intracellular pharmacokinetics of a model compound—that is, the 18F-labeled antibiotic 18F-ciprofloxacin—in vivo in humans. Methods: Ten healthy male volunteers received a mixture of 687 ± 50 MBq of 18F-ciprofloxacin and 200 mg of unlabeled ciprofloxacin as an intravenous bolus infusion over 10 min. The pharmacokinetics of ciprofloxacin in skeletal muscle tissue were assessed by means of combined PET and in vivo microdialysis for 5 h after drug administration. A 3-compartment pharmacokinetic model was fitted to the tissue concentration−time profiles of ciprofloxacin measured by PET to estimate the rate constants of ciprofloxacin uptake and transport. Results: In muscle tissue, mean total and extracellular peak concentration (Cmax) values of ciprofloxacin of 1.8 ± 0.4 μg/mL and 0.7 ± 0.2 μg/mL were attained at 95 ± 34 min and 48 ± 20 min after drug administration, respectively. The extracellular-to-intracellular exchange appeared to be very fast, with an estimated rate constant k3 of 1.69 ± 0.25 min−1. An intracellular-to-extracellular concentration ratio (Cintra/Cextra) of 3.2 ± 0.8 was reached at 110 min after injection and followed by sustained intracellular retention of the antibiotic for the remainder of the experiment. The predicted extracellular concentration−time profiles from the compartmental modeling were in good agreement with the measured microdialysis data. Conclusion: The results obtained in the present study were in accordance with previous in vitro data describing cellular ciprofloxacin uptake and retention. The presently used PET/microdialysis combination might be useful during research and development of new drugs, for which knowledge of intracellular concentrations is of interest.

  • PET
  • microdialysis
  • humans
  • intracellular concentration
  • ciprofloxacin

Footnotes

  • Received Apr. 29, 2005; revision accepted Aug. 3, 2005.

    For correspondence or reprints contact: Oliver Langer, PhD, Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Währinger-Gürtel 18-20, 1090 Vienna, Austria.

    E-mail: oliver.langer{at}meduniwien.ac.at

View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (11)
Journal of Nuclear Medicine
Vol. 46, Issue 11
November 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans
Oliver Langer, Rudolf Karch, Ulrich Müller, Georg Dobrozemsky, Aiman Abrahim, Markus Zeitlinger, Edith Lackner, Christian Joukhadar, Robert Dudczak, Kurt Kletter, Markus Müller, Martin Brunner
Journal of Nuclear Medicine Nov 2005, 46 (11) 1835-1841;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans
Oliver Langer, Rudolf Karch, Ulrich Müller, Georg Dobrozemsky, Aiman Abrahim, Markus Zeitlinger, Edith Lackner, Christian Joukhadar, Robert Dudczak, Kurt Kletter, Markus Müller, Martin Brunner
Journal of Nuclear Medicine Nov 2005, 46 (11) 1835-1841;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of 14CO2 Production Rate Data
  • Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents
  • Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas
  • Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography
  • Application of PET/CT in the Development of Novel Anticancer Drugs
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire